J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 12 900 KRW 0.16% Market Closed
Market Cap: 976.4B KRW

Jeisys Medical Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jeisys Medical Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
J
Jeisys Medical Inc
KOSDAQ:287410
Net Income (Common)
â‚©28B
CAGR 3-Years
N/A
CAGR 5-Years
263%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Net Income (Common)
â‚©101.5B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Net Income (Common)
â‚©29.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Net Income (Common)
â‚©32.6B
CAGR 3-Years
94%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Net Income (Common)
-â‚©8.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
NextBioMedical Co Ltd
KOSDAQ:389650
Net Income (Common)
â‚©2.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jeisys Medical Inc
Glance View

Market Cap
974B KRW
Industry
Health Care

Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.

Intrinsic Value
16 979.4 KRW
Undervaluation 24%
Intrinsic Value
Price
J

See Also

What is Jeisys Medical Inc's Net Income (Common)?
Net Income (Common)
28B KRW

Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Net Income (Common) amounts to 28B KRW.

What is Jeisys Medical Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
263%

Over the last year, the Net Income (Common) growth was 7%.

Back to Top